Published in Infect Immun on August 01, 2005
Leprosy as a genetic model for susceptibility to common infectious diseases. Hum Genet (2008) 1.08
Leprosy as a genetic disease. Mamm Genome (2010) 1.02
Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol Cell Biol (2006) 0.90
Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy. Am J Pathol (2009) 0.82
Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection. Infect Immun (2006) 0.81
Lymphotoxin-alpha plays only a minor role in host resistance to respiratory infection with virulent type A Francisella tularensis in mice. Mediators Inflamm (2008) 0.78
Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med (1988) 12.95
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65
Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science (2003) 10.22
Defective CD8 T cell memory following acute infection without CD4 T cell help. Science (2003) 9.67
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature (1993) 7.10
TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol (2002) 3.96
Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol (1989) 3.90
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 3.78
Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol (1994) 3.02
Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity (1998) 2.73
Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J Exp Med (1991) 2.55
Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol (1990) 2.54
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 2.53
Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev (2003) 2.12
Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med (2002) 1.86
A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J Immunol (2001) 1.75
Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med (2001) 1.74
CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion. Proc Natl Acad Sci U S A (1992) 1.61
The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J Immunol (2003) 1.40
Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J Immunol (2002) 1.29
Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development. J Immunol (1998) 1.28
Chronic Listeria infection in SCID mice: requirements for the carrier state and the dual role of T cells in transferring protection or suppression. J Immunol (1998) 1.18
Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J Immunol (1999) 1.14
Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-gamma but requires TNF-alpha. J Immunol (1998) 1.13
Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J Immunol (2003) 1.11
Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin Immunol (2000) 1.06
Cutting edge: antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice. J Immunol (2000) 1.02
Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J Immunol (2001) 1.01
Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo. Blood (2003) 0.99
Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J Virol (2002) 0.99
Differential effects of TNF and LTalpha in the host defense against M. bovis BCG. Eur J Immunol (2001) 0.99
Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs. Eur J Immunol (2002) 0.87
Membrane lymphotoxin is required for resistance to Theiler's virus infection. Int Immunol (2003) 0.83
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature (1986) 3.51
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy (1987) 2.81
Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun (2000) 2.63
Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun (1999) 2.57
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med (2001) 1.74
An inducible expression system permitting the efficient purification of a recombinant antigen from Mycobacterium smegmatis. FEMS Microbiol Lett (1998) 1.70
Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect Immun (2001) 1.60
T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect Immun (1994) 1.59
Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immunol (1996) 1.54
Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy (2002) 1.51
Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect Immun (1999) 1.49
Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J Immunol (2000) 1.47
Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells. Eur J Immunol (1999) 1.44
Prevalence of bronchial hyperresponsiveness in children: the relationship between asthma and skin reactivity to allergens in two communities. Int J Epidemiol (1986) 1.43
Immunological basis for reactivation of tuberculosis in mice. Infect Immun (2001) 1.42
Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis. J Infect Dis (1994) 1.36
Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J Immunol Methods (1994) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. III. Effect of exposure to environmental allergens. Clin Allergy (1987) 1.30
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. II. Relative importance of associated factors. Clin Allergy (1987) 1.25
The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24
The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy. J Exp Med (1991) 1.17
A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae. Infect Immun (1996) 1.17
Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses. Int J Lepr Other Mycobact Dis (1990) 1.16
CD4+ and CD8+ T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guérin. J Infect Dis (2000) 1.15
Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol (2000) 1.12
Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study. Allergy (1996) 1.12
Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. Scand J Immunol (1996) 1.10
Characterization of the gene encoding the immunodominant 35 kDa protein of Mycobacterium leprae. Mol Microbiol (1995) 1.09
The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol (1997) 1.08
Early predictors for developing allergic disease and asthma: examining separate steps in the 'allergic march'. Clin Exp Allergy (2007) 1.07
T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin Exp Immunol (2004) 1.06
Analysis of the internal transcribed spacer regions of ribosomal DNA in common airborne allergenic fungi. Electrophoresis (1997) 1.06
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04
A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion. Infect Immun (1998) 1.02
Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infect Immun (2001) 1.02
Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol (2001) 1.01
Mechanism of interaction of the 85B secreted protein of Mycobacterium bovis with fibronectin. Infect Immun (1993) 1.00
Rapid method for diagnosis of leprosy by measurements of antibodies to the M. leprae 35-kDa protein: comparison with PGL-I antibodies detected by ELISA and "dipstick" methods. Int J Lepr Other Mycobact Dis (1999) 0.98
Intentional chloroquine overdosage. Med J Aust (1978) 0.97
Isolation of strong expression signals of Mycobacterium tuberculosis. Microbiology (2001) 0.96
Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope. Int Immunol (2001) 0.94
Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes. Clin Exp Immunol (2000) 0.94
Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein. Infect Immun (1998) 0.94
The genetic control of susceptibility to Mycobacterium tuberculosis. Novartis Found Symp (2007) 0.93
The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect Immun (1992) 0.92
Risk factors for type-1 reactions in borderline leprosy patients. Lancet (1991) 0.92
T cell clones from a non-leprosy exposed subject recognize the Mycobacterium leprae 18-kD protein. Clin Exp Immunol (1995) 0.89
Serological monitoring of the response to chemotherapy in leprosy patients. Int J Lepr Other Mycobact Dis (1993) 0.89
Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein. Infect Immun (1993) 0.89
Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect Immun (1999) 0.88
Subclinical infection with Mycobacterium leprae--a problem for leprosy control strategies. Trans R Soc Trop Med Hyg (1993) 0.87
Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells. Infect Immun (2000) 0.87
Heterogeneity of serological responses in paucibacillary leprosy--differential responses to protein and carbohydrate antigens and correlation with clinical parameters. Int J Lepr Other Mycobact Dis (1990) 0.87
Cellular immune responses to mycobacterial heat shock proteins in Nepali leprosy patients and controls. Int J Lepr Other Mycobact Dis (1992) 0.86
Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae. Infect Immun (1996) 0.85
Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. Infect Immun (1997) 0.85
Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus. Immunol Cell Biol (2001) 0.84
DNA encoding a single mycobacterial antigen protects against leprosy infection. Vaccine (2001) 0.84
Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients. Int J Lepr Other Mycobact Dis (1992) 0.84
Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae. Int J Lepr Other Mycobact Dis (2001) 0.84
Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant (2006) 0.83
Characterization of the functional properties of the 70-kDa protein of Mycobacterium bovis. J Biol Chem (1991) 0.83
Immunopurification of radiolabelled antigens of Mycobacterium leprae and Mycobacterium bovis (bacillus Calmette-Guerin) with monoclonal antibodies. Scand J Immunol (1987) 0.83
Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen. Clin Exp Immunol (1993) 0.83
Renal sympathetic and cardiac changes associated with anaphylactic hypotension. Auton Neurosci (2004) 0.82
Drug resistance in Nepali leprosy patients. Int J Lepr Other Mycobact Dis (1996) 0.82
Specific serological diagnosis of leprosy with a recombinant Mycobacterium leprae protein purified from a rapidly growing mycobacterial host. J Clin Microbiol (1998) 0.82
Immunoblotting analysis of twin sera provides evidence for limited genetic control of specific IgE to house dust mite allergens. J Allergy Clin Immunol (1998) 0.81
Limited genetic control of specific IgE responses to rye grass pollen allergens in Australian twins. Clin Exp Allergy (1998) 0.80
Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy. Clin Exp Immunol (1992) 0.80
The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients. Am J Trop Med Hyg (1991) 0.79
Evidence for the genetic control of immunoglobulin E reactivity to the allergens of Alternaria alternata. Clin Exp Allergy (2002) 0.79
Schwann cells are able to present exogenous mycobacterial hsp70 to antigen-specific T lymphocytes. J Neuroimmunol (1993) 0.79
A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice. J Leukoc Biol (2000) 0.78
Separate antigenic determinants on cell wall associated carbohydrate antigens of Mycobacterium leprae defined with monoclonal antibodies. Int J Lepr Other Mycobact Dis (1986) 0.78
Identification of a Mycobacterium leprae-specific T cell epitope on the 70 kDa heat shock protein. Immunol Cell Biol (1994) 0.77
Effect of phthiocerol dimycocerosate deficiency on the transcriptional response of human macrophages to Mycobacterium tuberculosis. Microbes Infect (2006) 0.77
Risk factors associated with hepatitis B infection in antenatal patients. Aust N Z J Med (1985) 0.77
Sequence and expression of the Mycobacterium leprae dnaJ gene. J Gen Microbiol (1993) 0.76
Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection. Clin Exp Immunol (2001) 0.75
Nurse's role in day care. Gerontol Clin (Basel) (1974) 0.75